Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Cytokine1 who wrote (4464)	3/23/1998 9:28:00 PM
From: Andreas Helke	Respond to of 9719

Does anybody know some thing about the company Corixa CRXA? It develops vaccines particularly against cancer. I stumbled across this company when I read a bullish Lehmans Brothers report in february. They had a strong buy and a target price of $25 while the shares traded above $8. Now the shares have dropped from $14 after the IPO which probably was in september to $7.50. Current market cap is 89 million. With a price/book of 1.75, price/sales of 4.68, a price at its all time low and two strong buys as analyst recommendations the package was compelling enough for me to buy a few shares. The company has the strategy to keep its expenses low by partnering early. Unfortunately the company is years away from earnings and has just two phase I trials. Normally I prefer companies that are closer to approved products and positive earnings. Andreas